Table 3.
No. total patients |
No. diabetics |
Hazard Ratio† (95% CI) |
p | p – interaction by race†† |
p – interaction by obesity††† |
|
---|---|---|---|---|---|---|
Overall** | 1240 | 226 | 0.94 (0.72 - 1.23) | 0.67 | 0.09 | |
White | 659 | 99 | 1.24 (0.84 - 1.85) | 0.28 | 0.006 | |
Non obese | 479 | 55 | 0.69 (0.36 - 1.32) | 0.26 | ||
Obese | 180 | 44 | 2.52 (1.40 - 4.54) | 0.002 | ||
Black | 581 | 127 | 0.79 (0.55 - 1.14) | 0.21 | 0.91 | |
Non obese | 402 | 71 | 0.75 (0.45 - 1.25) | 0.27 | ||
Obese | 179 | 56 | 0.89 (0.52 - 1.54) | 0.68 |
Obesity was defined as a BMI ≥ 30 kg/m2
22 men were missing follow-up and not included in these analyses
Adjusted for age, year of surgery, race, BMI, clinical stage, biopsy Gleason score, center, and pre-operative PSA
p – interaction by race assessed by including the cross product term between diabetes and race in the model
p – interaction by obesity assessed by including the cross product term between obesity and race in the model